Selected research
Industry Research
Mouse Monoclonal Antibody Production Service Industry Research Report 2026
Market perspective
The global Mouse Monoclonal Antibody Production Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Mouse Monoclonal Antibody Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Mouse Monoclonal Antibody Production Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Mouse Monoclonal Antibody Production Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Mouse Monoclonal Antibody Production Service include Thermo Fisher Scientific, GenScript, Sino Biological, ProMab, Sydlabs, Rockland Immunochemicals, Inc, Boster Bio, Antibodies Incorporated and Creative Diagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Mouse Monoclonal Antibody Production Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Mouse Monoclonal Antibody Production Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mouse Monoclonal Antibody Production Service Market by Company
Thermo Fisher Scientific
GenScript
Sino Biological
ProMab
Sydlabs
Rockland Immunochemicals, Inc
Boster Bio
Antibodies Incorporated
Creative Diagnostics
Synaptic Systems
Inotiv Bioproducts
ProSpec
Applied Biological Materials Inc. (abm)
Creative Biolabs
Abvigen
R&D Systems
Eurogentec
Mouse Monoclonal Antibody Production Service Segment by Type
Hybridoma Technology
Phage Display Technology
Single B Cell Cloning Technology
Mouse Monoclonal Antibody Production Service Segment by Application
Biomedical Research
Diagnostics
Others
Mouse Monoclonal Antibody Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mouse Monoclonal Antibody Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mouse Monoclonal Antibody Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mouse Monoclonal Antibody Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mouse Monoclonal Antibody Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hybridoma Technology
- Phage Display Technology
- Single B Cell Cloning Technology
Applications
- Biomedical Research
- Diagnostics
- Others
Companies covered
- Thermo Fisher Scientific
- GenScript
- Sino Biological
- ProMab
- Sydlabs
- Rockland Immunochemicals, Inc
- Boster Bio
- Antibodies Incorporated
- Creative Diagnostics
- Synaptic Systems
- Inotiv Bioproducts
- ProSpec
- Applied Biological Materials Inc. (abm)
- Creative Biolabs
- Abvigen
- R&D Systems
- Eurogentec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Mouse Monoclonal Antibody Production Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hybridoma Technology
- 2.2.3 Phage Display Technology
- 2.2.4 Single B Cell Cloning Technology
- 2.3 Mouse Monoclonal Antibody Production Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedical Research
- 2.3.3 Diagnostics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Mouse Monoclonal Antibody Production Service Breakdown Data by Type
- 3.1 Global Mouse Monoclonal Antibody Production Service Historic Market Size by Type (2021-2026)
- 3.2 Global Mouse Monoclonal Antibody Production Service Forecasted Market Size by Type (2027-2032)
4 Mouse Monoclonal Antibody Production Service Breakdown Data by Application
- 4.1 Global Mouse Monoclonal Antibody Production Service Historic Market Size by Application (2021-2026)
- 4.2 Global Mouse Monoclonal Antibody Production Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Mouse Monoclonal Antibody Production Service Market Perspective (2021-2032)
- 5.2 Global Mouse Monoclonal Antibody Production Service Growth Trends by Region
- 5.2.1 Global Mouse Monoclonal Antibody Production Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Mouse Monoclonal Antibody Production Service Historic Market Size by Region (2021-2026)
- 5.2.3 Mouse Monoclonal Antibody Production Service Forecasted Market Size by Region (2027-2032)
- 5.3 Mouse Monoclonal Antibody Production Service Market Dynamics
- 5.3.1 Mouse Monoclonal Antibody Production Service Industry Trends
- 5.3.2 Mouse Monoclonal Antibody Production Service Market Drivers
- 5.3.3 Mouse Monoclonal Antibody Production Service Market Challenges
- 5.3.4 Mouse Monoclonal Antibody Production Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Mouse Monoclonal Antibody Production Service Players by Revenue
- 6.1.1 Global Top Mouse Monoclonal Antibody Production Service Players by Revenue (2021-2026)
- 6.1.2 Global Mouse Monoclonal Antibody Production Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Mouse Monoclonal Antibody Production Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Mouse Monoclonal Antibody Production Service Head Office and Area Served
- 6.4 Global Mouse Monoclonal Antibody Production Service Players, Product Type & Application
- 6.5 Global Mouse Monoclonal Antibody Production Service Manufacturers Established Date
- 6.6 Global Mouse Monoclonal Antibody Production Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Mouse Monoclonal Antibody Production Service Market Size (2021-2032)
- 7.2 North America Mouse Monoclonal Antibody Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Mouse Monoclonal Antibody Production Service Market Size by Country (2021-2026)
- 7.4 North America Mouse Monoclonal Antibody Production Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Mouse Monoclonal Antibody Production Service Market Size (2021-2032)
- 8.2 Europe Mouse Monoclonal Antibody Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Mouse Monoclonal Antibody Production Service Market Size by Country (2021-2026)
- 8.4 Europe Mouse Monoclonal Antibody Production Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Mouse Monoclonal Antibody Production Service Market Size (2021-2032)
- 9.2 Asia-Pacific Mouse Monoclonal Antibody Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Mouse Monoclonal Antibody Production Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Mouse Monoclonal Antibody Production Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Mouse Monoclonal Antibody Production Service Market Size (2021-2032)
- 10.2 South America Mouse Monoclonal Antibody Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Mouse Monoclonal Antibody Production Service Market Size by Country (2021-2026)
- 10.4 South America Mouse Monoclonal Antibody Production Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Mouse Monoclonal Antibody Production Service Market Size (2021-2032)
- 11.2 Middle East & Africa Mouse Monoclonal Antibody Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Mouse Monoclonal Antibody Production Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Mouse Monoclonal Antibody Production Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 GenScript
- 12.2.1 GenScript Company Information
- 12.2.2 GenScript Business Overview
- 12.2.3 GenScript Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.2.4 GenScript Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.2.5 GenScript Recent Developments
- 12.3 Sino Biological
- 12.3.1 Sino Biological Company Information
- 12.3.2 Sino Biological Business Overview
- 12.3.3 Sino Biological Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.3.4 Sino Biological Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.3.5 Sino Biological Recent Developments
- 12.4 ProMab
- 12.4.1 ProMab Company Information
- 12.4.2 ProMab Business Overview
- 12.4.3 ProMab Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.4.4 ProMab Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.4.5 ProMab Recent Developments
- 12.5 Sydlabs
- 12.5.1 Sydlabs Company Information
- 12.5.2 Sydlabs Business Overview
- 12.5.3 Sydlabs Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.5.4 Sydlabs Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.5.5 Sydlabs Recent Developments
- 12.6 Rockland Immunochemicals, Inc
- 12.6.1 Rockland Immunochemicals, Inc Company Information
- 12.6.2 Rockland Immunochemicals, Inc Business Overview
- 12.6.3 Rockland Immunochemicals, Inc Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.6.4 Rockland Immunochemicals, Inc Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.6.5 Rockland Immunochemicals, Inc Recent Developments
- 12.7 Boster Bio
- 12.7.1 Boster Bio Company Information
- 12.7.2 Boster Bio Business Overview
- 12.7.3 Boster Bio Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.7.4 Boster Bio Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.7.5 Boster Bio Recent Developments
- 12.8 Antibodies Incorporated
- 12.8.1 Antibodies Incorporated Company Information
- 12.8.2 Antibodies Incorporated Business Overview
- 12.8.3 Antibodies Incorporated Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.8.4 Antibodies Incorporated Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.8.5 Antibodies Incorporated Recent Developments
- 12.9 Creative Diagnostics
- 12.9.1 Creative Diagnostics Company Information
- 12.9.2 Creative Diagnostics Business Overview
- 12.9.3 Creative Diagnostics Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.9.4 Creative Diagnostics Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.9.5 Creative Diagnostics Recent Developments
- 12.10 Synaptic Systems
- 12.10.1 Synaptic Systems Company Information
- 12.10.2 Synaptic Systems Business Overview
- 12.10.3 Synaptic Systems Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.10.4 Synaptic Systems Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.10.5 Synaptic Systems Recent Developments
- 12.11 Inotiv Bioproducts
- 12.11.1 Inotiv Bioproducts Company Information
- 12.11.2 Inotiv Bioproducts Business Overview
- 12.11.3 Inotiv Bioproducts Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.11.4 Inotiv Bioproducts Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.11.5 Inotiv Bioproducts Recent Developments
- 12.12 ProSpec
- 12.12.1 ProSpec Company Information
- 12.12.2 ProSpec Business Overview
- 12.12.3 ProSpec Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.12.4 ProSpec Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.12.5 ProSpec Recent Developments
- 12.13 Applied Biological Materials Inc. (abm)
- 12.13.1 Applied Biological Materials Inc. (abm) Company Information
- 12.13.2 Applied Biological Materials Inc. (abm) Business Overview
- 12.13.3 Applied Biological Materials Inc. (abm) Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.13.4 Applied Biological Materials Inc. (abm) Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.13.5 Applied Biological Materials Inc. (abm) Recent Developments
- 12.14 Creative Biolabs
- 12.14.1 Creative Biolabs Company Information
- 12.14.2 Creative Biolabs Business Overview
- 12.14.3 Creative Biolabs Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.14.4 Creative Biolabs Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.14.5 Creative Biolabs Recent Developments
- 12.15 Abvigen
- 12.15.1 Abvigen Company Information
- 12.15.2 Abvigen Business Overview
- 12.15.3 Abvigen Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.15.4 Abvigen Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.15.5 Abvigen Recent Developments
- 12.16 R&D Systems
- 12.16.1 R&D Systems Company Information
- 12.16.2 R&D Systems Business Overview
- 12.16.3 R&D Systems Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.16.4 R&D Systems Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.16.5 R&D Systems Recent Developments
- 12.17 Eurogentec
- 12.17.1 Eurogentec Company Information
- 12.17.2 Eurogentec Business Overview
- 12.17.3 Eurogentec Revenue in Mouse Monoclonal Antibody Production Service Business (2021-2026)
- 12.17.4 Eurogentec Mouse Monoclonal Antibody Production Service Product Portfolio
- 12.17.5 Eurogentec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst